Free Trial
OTCMKTS:USAQ

QHSLab (USAQ) Stock Price, News & Analysis

QHSLab logo
$0.21 -0.02 (-8.70%)
As of 11:32 AM Eastern

About QHSLab Stock (OTCMKTS:USAQ)

Key Stats

Today's Range
$0.21
$0.21
50-Day Range
$0.15
$0.33
52-Week Range
$0.08
$0.47
Volume
6,204 shs
Average Volume
21,366 shs
Market Capitalization
$2.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.

Receive USAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QHSLab and its competitors with MarketBeat's FREE daily newsletter.

USAQ Stock News Headlines

QHSLab (OTCMKTS:USAQ) Stock Price Up 8.6% - Still a Buy?
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
USA Equities Engages Hayden IR for Investor Relations
See More Headlines

USAQ Stock Analysis - Frequently Asked Questions

QHSLab's stock was trading at $0.2480 at the beginning of 2025. Since then, USAQ stock has decreased by 15.3% and is now trading at $0.21.
View the best growth stocks for 2025 here
.

QHSLab, Inc. (OTCMKTS:USAQ) announced its quarterly earnings data on Wednesday, May, 14th. The company reported ($0.01) EPS for the quarter. The company earned $0.65 million during the quarter.

Shares of USAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that QHSLab investors own include AMER PREM WATER (HIPH), Ultrack Systems (MJLB), Meta Platforms (META), Isracann Biosciences (ISCNF), International Land Alliance (ILAL), Leef Brands (ICNAF) and Gemini Group Global (GMNI).

Company Calendar

Last Earnings
5/14/2025
Today
6/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:USAQ
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$260 thousand
Pretax Margin
-13.99%

Debt

Sales & Book Value

Annual Sales
$2.13 million
Price / Cash Flow
N/A
Book Value
($0.06) per share
Price / Book
-3.50

Miscellaneous

Free Float
2,734,000
Market Cap
$2.22 million
Optionable
Not Optionable
Beta
0.77
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (OTCMKTS:USAQ) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners